Skip to Content

MONDAY, 15 SEPTEMBER 2025, 14:21

World

NPR revisits HIV/AIDS patients who lost access to meds after Trump cut foreign aid

Today at 11:30 AM, via NPR

In April 2025, NPR looked at the impact of President Trump’s cuts to foreign aid on HIV positive individuals in Zambia. Many were falling sick without access to their HIV medications. We returned to those people, as well as others who keep close tabs on the HIV/AIDS situation, to see where things stand now. Reporter: Gabrielle Emanuel. Editor: Rebecca Davis. Digital Editor: Marc Silver.

Business

Bad news for digital driving licences in South Africa

Today at 13:19 PM, via BusinessTech

While there have been suggestions and even a concerted push for the adoption of a digital driving licence in South Africa, experts say the country simply isn’t ready for it.

Science/Tech

Sensani Innovating Health Care Hygiene In South Africa

Today at 14:14 PM, via Tech Financials

In the heart of Johannesburg, Sensani the leading innovation of Mkazi Concepts is a proudly black and youth-led enterprise driving a mission to reshape what hygiene compliance is in South Africa. Safeguarding communities through technology. Simphiwe Peace Mjwara, the founder of Mkazi Concepts highlights that the Sansai is a next-generation hygiene compliance platform that combines […]

Science/Tech

Solana Price Prediction; Bonk Coin Latest News & Which Crypto Is The Next 100x

Today at 14:08 PM, via Tech Financials

Solana price prediction models suggest solid growth potential through 2025, while Bonk coin latest news indicates mixed developments for the meme token. Amid these established projects, Layer Brett ($LBRETT) emerges. It’s a strong contender for exceptional returns. And it could dwarf what larger tokens can achieve. This contrast highlights the different opportunities available to...

Health

When a Simple Swim Carries a Risk of Dangerous Illness

Today at 11:00 AM, via New York Times

The parasitic infection schistosomiasis affects an estimated 200 million people globally, many of them children. But campaigns to identify and treat it face formidable hurdles.